<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Autoantibodies on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/autoantibodies/</link><description>Recent content in Autoantibodies on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Mon, 18 May 2026 08:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/autoantibodies/index.xml" rel="self" type="application/rss+xml"/><item><title>Inflammatory Myopathies — A Contemporary Review</title><link>https://rheumatologydigest.org/posts/inflammatory-myopathies-review/</link><pubDate>Mon, 18 May 2026 08:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/inflammatory-myopathies-review/</guid><description>A contemporary NEJM review of idiopathic inflammatory myopathies — the five-subtype framework (IBM, IMNM, antisynthetase syndrome, overlap, dermatomyositis), the autoantibody revolution that now anchors classification, and the shift toward subtype-specific therapy with biologics, JAK/TYK2 inhibitors, and CAR-T.</description></item></channel></rss>